Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2016

13.04.2016 | Original Article – Clinical Oncology

Parotid melanoma of unknown primary

verfasst von: Jeffrey F. Scott, Cheryl L. Thompson, Ritva Vyas, Kord Honda, Chad Zender, Rod Rezaee, Pierre Lavertu, Henry Koon, Kevin D. Cooper, Meg R. Gerstenblith

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Rarely, melanoma is discovered in the parotid gland without an identifiable primary site. It is not known how patients with parotid melanoma of unknown primary (PMUP) compare to those with a known primary (PMKP). As such, we describe the largest series of patients with PMUP to date and compare them to patients with PMKP.

Methods

We analyzed cases from three sources: (1) the University Hospitals Case Medical Center pathology database (n = 45), (2) the Surveillance, Epidemiology, and End Results 18 database (n = 33), and (3) a comprehensive literature search (n = 32).

Results

PMUP patients were predominately male and presented at a mean age of 56 years. When compared to PMKP, PMUP cases were more likely to be diagnosed in the parotid parenchyma, present with stage IV disease, and develop distant metastases during follow-up in a shorter amount of time. However, there was no difference in overall survival between patients with PMUP and PMKP presenting with stage-matched disease.

Conclusions

Overall survival is similar for stage-matched patients with parotid melanoma presenting with an unknown and known primary site.
Literatur
Zurück zum Zitat Bae JM, Choi YY, Kim DS et al (2015) Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 72:59–70CrossRefPubMed Bae JM, Choi YY, Kim DS et al (2015) Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 72:59–70CrossRefPubMed
Zurück zum Zitat Bahar M, Anavi Y, Abraham A et al (1990) Primary malignant melanoma in the parotid gland. Oral Surg Oral Med Oral Pathol 70:627–630CrossRefPubMed Bahar M, Anavi Y, Abraham A et al (1990) Primary malignant melanoma in the parotid gland. Oral Surg Oral Med Oral Pathol 70:627–630CrossRefPubMed
Zurück zum Zitat Ballo MT, Bonnen MD, Garden AS et al (2003) Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 97:1789–1796CrossRefPubMed Ballo MT, Bonnen MD, Garden AS et al (2003) Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 97:1789–1796CrossRefPubMed
Zurück zum Zitat Balm AJ, Kroon BB, Hilgers FJ et al (1994) Lymph node metastases in the neck and parotid gland from an unknown primary melanoma. Clin Otolaryngol Allied Sci 19:161–165CrossRefPubMed Balm AJ, Kroon BB, Hilgers FJ et al (1994) Lymph node metastases in the neck and parotid gland from an unknown primary melanoma. Clin Otolaryngol Allied Sci 19:161–165CrossRefPubMed
Zurück zum Zitat Barbieri M, Gentile R, Cordone MP et al (2002) Primitive malignant melanoma of the parotid gland. J Oto Rhino Laryngol Relat Spec 64:297–299 Barbieri M, Gentile R, Cordone MP et al (2002) Primitive malignant melanoma of the parotid gland. J Oto Rhino Laryngol Relat Spec 64:297–299
Zurück zum Zitat Bussi M, Cardarelli L, Riontino E et al (1999) Primary malignant melanoma arising in the parotid gland: case report and literature review. Tumori 85:523–525PubMed Bussi M, Cardarelli L, Riontino E et al (1999) Primary malignant melanoma arising in the parotid gland: case report and literature review. Tumori 85:523–525PubMed
Zurück zum Zitat Conley J, Arena S (1963) Parotid gland as a focus for metastasis. Arch Surg (Chicago, IL 1960) 87:757–764 Conley J, Arena S (1963) Parotid gland as a focus for metastasis. Arch Surg (Chicago, IL 1960) 87:757–764
Zurück zum Zitat Cooper PH, Wanebo HJ, Hagar RW (1985) Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol 121:1127–1131CrossRefPubMed Cooper PH, Wanebo HJ, Hagar RW (1985) Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol 121:1127–1131CrossRefPubMed
Zurück zum Zitat Dasgupta T, Bowden L, Berg JW (1963) Malignant melanoma of unknown primary origin. Surg Gynecol Obstet 117:341–345PubMed Dasgupta T, Bowden L, Berg JW (1963) Malignant melanoma of unknown primary origin. Surg Gynecol Obstet 117:341–345PubMed
Zurück zum Zitat Ettl T, Irga S, Muller S et al (2014) Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas. J Cranio-Maxillo Facial Surg 42:e252–e258CrossRef Ettl T, Irga S, Muller S et al (2014) Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas. J Cranio-Maxillo Facial Surg 42:e252–e258CrossRef
Zurück zum Zitat Gao N, Li LJ, Li Y et al (2008) Primary amelanotic malignant melanoma of the parotid gland: a case report. J Int Med Res 36:1435–1439CrossRefPubMed Gao N, Li LJ, Li Y et al (2008) Primary amelanotic malignant melanoma of the parotid gland: a case report. J Int Med Res 36:1435–1439CrossRefPubMed
Zurück zum Zitat Geltzeiler M, Monroe M, Givi B et al (2014) Regional control of head and neck melanoma with selective neck dissection. JAMA Otolaryngol Head Neck Surg 140:1014–1018CrossRefPubMed Geltzeiler M, Monroe M, Givi B et al (2014) Regional control of head and neck melanoma with selective neck dissection. JAMA Otolaryngol Head Neck Surg 140:1014–1018CrossRefPubMed
Zurück zum Zitat Greene GW Jr, Bernier JL (1961) Primary malignant melanomas of the parotid gland. Oral Surg Oral Med Oral Pathol 14:108–116CrossRefPubMed Greene GW Jr, Bernier JL (1961) Primary malignant melanomas of the parotid gland. Oral Surg Oral Med Oral Pathol 14:108–116CrossRefPubMed
Zurück zum Zitat High WA, Stewart D, Wilbers CR et al (2005) Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria. J Am Acad Dermatol 53:89–100CrossRefPubMed High WA, Stewart D, Wilbers CR et al (2005) Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria. J Am Acad Dermatol 53:89–100CrossRefPubMed
Zurück zum Zitat Hoersch B, Leiter U, Garbe C (2006) Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol 155:771–777CrossRefPubMed Hoersch B, Leiter U, Garbe C (2006) Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol 155:771–777CrossRefPubMed
Zurück zum Zitat Jennings TA, Okby NT, Schroer KR et al (1996) Parotid involvement by desmoplastic melanoma. Histopathology 29:165–170CrossRefPubMed Jennings TA, Okby NT, Schroer KR et al (1996) Parotid involvement by desmoplastic melanoma. Histopathology 29:165–170CrossRefPubMed
Zurück zum Zitat Kamposioras K, Pentheroudakis G, Pectasides D et al (2011) Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature. Crit Rev Oncol Hematol 78:112–126CrossRefPubMed Kamposioras K, Pentheroudakis G, Pectasides D et al (2011) Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature. Crit Rev Oncol Hematol 78:112–126CrossRefPubMed
Zurück zum Zitat Karpowicz MK, Shalmon B, Molberg KH et al (2011) Melanoma in a carcinoma ex pleomorphic adenoma of the parotid gland: a case report and putative histogenesis. Hum Pathol 42:1355–1358CrossRefPubMed Karpowicz MK, Shalmon B, Molberg KH et al (2011) Melanoma in a carcinoma ex pleomorphic adenoma of the parotid gland: a case report and putative histogenesis. Hum Pathol 42:1355–1358CrossRefPubMed
Zurück zum Zitat Klausner JM, Gutman M, Inbar M et al (1983) Unknown primary melanoma. J Surg Oncol 24:129–131CrossRefPubMed Klausner JM, Gutman M, Inbar M et al (1983) Unknown primary melanoma. J Surg Oncol 24:129–131CrossRefPubMed
Zurück zum Zitat Lachiewicz AM, Berwick M, Wiggins CL et al (2008) Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 144:515–521CrossRefPubMed Lachiewicz AM, Berwick M, Wiggins CL et al (2008) Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 144:515–521CrossRefPubMed
Zurück zum Zitat Laudadio P, Rinaldi Ceroni A, Cerasoli PT (1984) Metastatic malignant melanoma in the parotid gland. J Oto Rhino Laryngol Relat Spec 46:42–49 Laudadio P, Rinaldi Ceroni A, Cerasoli PT (1984) Metastatic malignant melanoma in the parotid gland. J Oto Rhino Laryngol Relat Spec 46:42–49
Zurück zum Zitat Lussier C, Klijanienko J, Vielh P (2000) Fine-needle aspiration of metastatic nonlymphomatous tumors to the major salivary glands: a clinicopathologic study of 40 cases cytologically diagnosed and histologically correlated. Cancer 90:350–356CrossRefPubMed Lussier C, Klijanienko J, Vielh P (2000) Fine-needle aspiration of metastatic nonlymphomatous tumors to the major salivary glands: a clinicopathologic study of 40 cases cytologically diagnosed and histologically correlated. Cancer 90:350–356CrossRefPubMed
Zurück zum Zitat Mesa M, Quesada JL, Pinas J (2009) Metastasis of amelanotic melanoma of unknown origin in the parotid gland. Br J Oral Maxillofac Surg 47:569–571CrossRefPubMed Mesa M, Quesada JL, Pinas J (2009) Metastasis of amelanotic melanoma of unknown origin in the parotid gland. Br J Oral Maxillofac Surg 47:569–571CrossRefPubMed
Zurück zum Zitat Nasri S, Namazie A, Dulguerov P et al (1994) Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site. Laryngoscope 104:1194–1198PubMed Nasri S, Namazie A, Dulguerov P et al (1994) Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site. Laryngoscope 104:1194–1198PubMed
Zurück zum Zitat Nichols RD, Pinnock LA, Szymanowski RT (1980) Metastases to parotid nodes. Laryngoscope 90:1324–1328PubMed Nichols RD, Pinnock LA, Szymanowski RT (1980) Metastases to parotid nodes. Laryngoscope 90:1324–1328PubMed
Zurück zum Zitat Nuyens M, Schupbach J, Stauffer E et al (2006) Metastatic disease to the parotid gland. Otolaryngol Head Neck Surg 135:844–848CrossRefPubMed Nuyens M, Schupbach J, Stauffer E et al (2006) Metastatic disease to the parotid gland. Otolaryngol Head Neck Surg 135:844–848CrossRefPubMed
Zurück zum Zitat O’Brien CJ, Petersen-Schafer K, Papadopoulos T et al (1994) Evaluation of 107 therapeutic and elective parotidectomies for cutaneous melanoma. Am J Surg 168:400–403CrossRefPubMed O’Brien CJ, Petersen-Schafer K, Papadopoulos T et al (1994) Evaluation of 107 therapeutic and elective parotidectomies for cutaneous melanoma. Am J Surg 168:400–403CrossRefPubMed
Zurück zum Zitat O’Brien CJ, Uren RF, Thompson JF et al (1995) Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 170:461–466CrossRefPubMed O’Brien CJ, Uren RF, Thompson JF et al (1995) Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 170:461–466CrossRefPubMed
Zurück zum Zitat O’Brien CJ, Petersen-Schaefer K, Stevens GN et al (1997) Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 19:589–594CrossRefPubMed O’Brien CJ, Petersen-Schaefer K, Stevens GN et al (1997) Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 19:589–594CrossRefPubMed
Zurück zum Zitat O’Brien CJ, McNeil EB, McMahon JD et al (2001) Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 23:744–748CrossRefPubMed O’Brien CJ, McNeil EB, McMahon JD et al (2001) Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 23:744–748CrossRefPubMed
Zurück zum Zitat Pain JA, Collier DS, Conn PC (1986) Malignant melanoma of a parotid lymph gland. An unusual case. Int J Oral Maxillofac Surg 15:645–647CrossRefPubMed Pain JA, Collier DS, Conn PC (1986) Malignant melanoma of a parotid lymph gland. An unusual case. Int J Oral Maxillofac Surg 15:645–647CrossRefPubMed
Zurück zum Zitat Prayson RA, Sebek BA (2000) Parotid gland malignant melanomas. Arch Pathol Lab Med 124:1780–1784PubMed Prayson RA, Sebek BA (2000) Parotid gland malignant melanomas. Arch Pathol Lab Med 124:1780–1784PubMed
Zurück zum Zitat Renaut AJ (1996) Melanoma arising within the parotid salivary gland—a case report and review of management. Eur J Surg Oncol 22:201–202CrossRefPubMed Renaut AJ (1996) Melanoma arising within the parotid salivary gland—a case report and review of management. Eur J Surg Oncol 22:201–202CrossRefPubMed
Zurück zum Zitat Santini H, Byers RM, Wolf PF (1985) Melanoma metastatic to cervical and parotid nodes from an unknown primary site. Am J Surg 150:510–512CrossRefPubMed Santini H, Byers RM, Wolf PF (1985) Melanoma metastatic to cervical and parotid nodes from an unknown primary site. Am J Surg 150:510–512CrossRefPubMed
Zurück zum Zitat Schroeder WA Jr, Stahr WD (1998) Malignant neoplastic disease of the parotid lymph nodes. Laryngoscope 108:1514–1519CrossRefPubMed Schroeder WA Jr, Stahr WD (1998) Malignant neoplastic disease of the parotid lymph nodes. Laryngoscope 108:1514–1519CrossRefPubMed
Zurück zum Zitat Supriya M, Narasimhan V, Henderson MA et al (2014) Managing regional metastasis in patients with cutaneous head and neck melanoma—is selective neck dissection appropriate? Am J Otolaryngol 35:610–616CrossRefPubMed Supriya M, Narasimhan V, Henderson MA et al (2014) Managing regional metastasis in patients with cutaneous head and neck melanoma—is selective neck dissection appropriate? Am J Otolaryngol 35:610–616CrossRefPubMed
Zurück zum Zitat Surveillance, Epidemiology, and End Results (SEER) program (http://www.seer.cancer.gov) SEER*Stat Database Incidence—18 Reg Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973–2011 varying)—Linked to County Attributes—Total U.S. 1969–2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2014), based on the November 2013 submission Surveillance, Epidemiology, and End Results (SEER) program (http://​www.​seer.​cancer.​gov) SEER*Stat Database Incidence—18 Reg Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973–2011 varying)—Linked to County Attributes—Total U.S. 1969–2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014 (updated 5/7/2014), based on the November 2013 submission
Zurück zum Zitat Thom JJ, Moore EJ, Price DL et al (2014) The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngol Head Neck Surg 140:548–554CrossRefPubMed Thom JJ, Moore EJ, Price DL et al (2014) The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngol Head Neck Surg 140:548–554CrossRefPubMed
Zurück zum Zitat Tsutsumida A, Yamamoto Y, Sekido M et al (2008) Suspected case of primary malignant melanoma of the parotid gland. Scand J Plastic Reconstruct Surg Hand Surg 42:105–107CrossRef Tsutsumida A, Yamamoto Y, Sekido M et al (2008) Suspected case of primary malignant melanoma of the parotid gland. Scand J Plastic Reconstruct Surg Hand Surg 42:105–107CrossRef
Zurück zum Zitat Wang BY, Lawson W, Robinson RA et al (1999) Malignant melanomas of the parotid: comparison of survival for patients with metastases from known vs unknown primary tumor sites. Arch Otolaryngol Head Neck Surg 125:635–639CrossRefPubMed Wang BY, Lawson W, Robinson RA et al (1999) Malignant melanomas of the parotid: comparison of survival for patients with metastases from known vs unknown primary tumor sites. Arch Otolaryngol Head Neck Surg 125:635–639CrossRefPubMed
Zurück zum Zitat Woodwards RT, Shepherd NA, Hensher R (1993) Malignant melanoma of the parotid gland: a case report and literature review. Br J Oral Maxillofac Surg 31:313–315CrossRefPubMed Woodwards RT, Shepherd NA, Hensher R (1993) Malignant melanoma of the parotid gland: a case report and literature review. Br J Oral Maxillofac Surg 31:313–315CrossRefPubMed
Metadaten
Titel
Parotid melanoma of unknown primary
verfasst von
Jeffrey F. Scott
Cheryl L. Thompson
Ritva Vyas
Kord Honda
Chad Zender
Rod Rezaee
Pierre Lavertu
Henry Koon
Kevin D. Cooper
Meg R. Gerstenblith
Publikationsdatum
13.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2156-x

Weitere Artikel der Ausgabe 7/2016

Journal of Cancer Research and Clinical Oncology 7/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.